Original Article

Relationship between Parathyroid Hormone Level and Early Remodeling Heart Failure after Acute Myocardial Infarction

Abstract

Background: Previous studies have indicated that parathyroid hormone (PTH) has been linked to post-myocardial infarction (MI) development. The aim of this cross-sectional study was to evaluate the relationship between PTH level and heart failure due to post infarction remodeling during the first 72 hours of hospitalization.
Methods: Seventy patients with a diagnosis of acute MI (age ≥18 years, 22 females and 48 males) were enrolled. Patients were admitted to the Imam Raza Educational, Research and Treatment Center, Mashhad University of Medical Sciences, Iran between July 2014 to September 2015. We measured PTH and vitamin D level. Blood samples were taken after 24 hours and 72 hours.
Results: During the first 72 hours, the PTH level significantly increased in patients with Post-MI heart failure. 68% of the subjects had an inappropriate vitamin D level at the time of admission. Mean levels of vitamin D and PTH increased compared with the baselines (95% CI, 0.15 to 10.03, P: 0.044), (95% CI, 6.5 to 24.8, P:0.001) respectively.
Conclusion: Acute elevations of serum PTH levels increased early remodeling heart failure after MI. Serum vitamin D status was independent of high serum PTH level. Based on the current evidence, PTH excess may be a risk factor for heart failure, so early treatment and omitting risk factors are the most effective strategies for the patients with acute myocardial infarction.

. Rozwadowska N, Kurpisz M. Myocardial Infarction. In: Xiao-Dong Chen, editor. A Roadmap to Nonhematopoietic Stem Cell-Based Therapeutics. Elsevier; 2019. p. 223-49.
2. Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell Tissue Res 2016;365(3):563-81.
3. Bhat P, Tang WHW. Biomarkers to Assess and Guide the Management of Heart Failure. In: Vijay Nambi, editor. Biomarkers in Cardiovascular Disease. Elsevier; 2019. p. 97-108.
4. Ho HCH, Maddaloni E, Buzzetti R. Risk Factors and Predicitve Biomarkers of Early Cardiovascular Disease in Obese Youth. Diabetes Metab Res Rev 2019;35(4):e3134.
5. Piek A, Du W, de Boer RA, Silljé HH. Novel heart failure biomarkers: why do we fail to exploit their potential? Crit Rev Clin Lab Sci 2018;55(4):246-63.
6. Ruiz PR, Huertas LJ, Sancirilo MC, et al. Parathyroid hormone, calcidiol, calcitriol and adverse events in the acute coronary syndrome. Med Intensiva 2018;42(2):73-81.
7. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92(1):39-48.
8. Bailey L, Smyl D, Bossuyt S, Bossuyt J. Quantifying nuclear remodeling in heart failure. Biophysical Journal 2018;114(3):499a.
9. Yagi S, Aihara K-i, Kondo T, et al. High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients. Endocr J 2014;61(7):727-33.
10. Abbasi SH, Sundin Ö, Jalali A, Soares J, Macassa G. Ethnic Differences in the Risk Factors and Severity of Coronary Artery Disease: a Patient-Based Study in Iran. J Racial Ethn Health Disparities 2018;5(3):623-631.
11. Kiernan TJ, O'Flynn AM, McDermott JH, Kearney P. Primary hyperparathyroidism and the cardiovascular system. Int J Cardiol 2006;113(3):E89-92.
12. Schierbeck LL, Jensen TS, Bang U, Jensen G, Køber L, Jensen JEB. Parathyroid hormone and vitamin D—markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 2011;13(6):626-32.
13. Zaruba M-M, Huber BC, Brunner S, et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77(4):722-31.
14. Zarei B, Mousavi M, Mehdizadeh S, Mehrad-Majd H, Zarif M, Erfanian Z, Moradi A. Early effects of atorvastatin on Vitamin D and parathyroid hormone serum levels following acute myocardial infarction. J Res Pharm Pract 2019;8(1):7-12.
15. Huber BC, Fischer R, Brunner S, et al. Comparison of parathyroid hormone and G-CSF treatment after myocardial infarction on perfusion and stem cell homing. Am J Physiol Heart Circ Physiol 2010;298(5):H1466-H71.
16. Gupta S. Disparities in multiple risk factors for cardiovascular diseases-Delaware, 2011. Del Med J 2014;86(3):77-84.
17. Kolaszko A, Nowalany-Kozielska E, Ceranowicz P, Morawiec B, Kubiak G. The role of parathyroid hormone and Vitamin D serum concentrations in patients with cardiovascular diseases. Dis Markers 2018;2018:5287573.
18. Bansal N, Zelnick L, Robinson‐Cohen C, et al. Serum parathyroid hormone and 25‐hydroxyvitamin D concentrations and risk of incident heart failure: the multi‐ethnic study of atherosclerosis. J Am Heart Assoc 2014;3(6):e001278.
19. Fujii H. Association between Parathyroid Hormone and Cardiovascular Disease. Ther Apher Dial 2018;22(3):236-41.
Files
IssueVol 8, No 1 (Winter 2020) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/jpc.v8i1.2741
Keywords
Myocardial Infarction Parathyroid Hormone; Hyperparathyroidism Vitamin D
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Firouzi Z, Mahdizadeh Sajjadieh S, Mousavi M, Erfanian Z, Zarif M. Relationship between Parathyroid Hormone Level and Early Remodeling Heart Failure after Acute Myocardial Infarction. J Pharm Care. 2020;8(1):11-15.